antibiotics

UTILITY Therapeutics Inks License Agreement for Two Antibiotics for the US Market
UTILITY Therapeutics Inks License Agreement for Two Antibiotics for the US Market
CP Wire
UTILITY Therapeutics
antibiotics
LEO Pharma
Flag link:
Phage-Based Therapy - A Primer
Phage-Based Therapy - A Primer
CP Wire
phages
bacteriophage
antibiotics
antibiotic resistance
Flag link:
Phage-Based Therapy - A Primer
phages
bacteriophage
antibiotics
Flag link:
Arrevus Receives NIH Fast-Track Grant to Develop ARV-1502 Against Multi-Drug Resistant Bacteremia
Arrevus Receives NIH Fast-Track Grant to Develop ARV-1502 Against Multi-Drug Resistant Bacteremia
CP Wire
Arrevus
antibiotics
ARV-1502
bacterenua
antibiotic resistance
Flag link:
J&J dumps a failed PhIII antibiotic program picked up in Actelion buyout
J&J dumps a failed PhIII antibiotic program picked up in Actelion buyout
Endpoints
JNJ
Actelion
antibiotics
C. difficile
cadazolid
Flag link:
Nosopharm and University of Chicago Researchers Report on New Class of Antibiotics
Nosopharm and University of Chicago Researchers Report on New Class of Antibiotics
CP Wire
Nosopharm
antibiotics
drug development
Flag link:
Genentech antibody spotlights new target for antibiotic-resistant bacteria
Genentech antibody spotlights new target for antibiotic-resistant bacteria
Fierce Biotech
Genentech
antibiotic resistance
antibiotics
R&D
drug discovery
BamA enzyme
Flag link:
After 20 years, Paratek’s broad-spectrum antibiotic is headed to the FDA
After 20 years, Paratek’s broad-spectrum antibiotic is headed to the FDA
Drug Delivery Business News
Paratek
antibiotics
broad spectrum antibiotics
FDA
omadacycline
Flag link:
Mid-FDA Review, Tetraphase Stumbles Again on Latest Phase 3 Setback
Mid-FDA Review, Tetraphase Stumbles Again on Latest Phase 3 Setback
Xconomy
FDA
Tetraphase Pharmaceuticals
clinical trials
Eravacycline
antibiotics
Flag link:
Merck spinout grabs some assets and launches a quest for the Holy Grail in antibiotics R&D
Merck spinout grabs some assets and launches a quest for the Holy Grail in antibiotics R&D
Endpoints
Merck
antibiotics
R&D
Prokaryotics
Flag link:
Big Pharma invests in research for new antibiotics ($2bn)
Big Pharma invests in research for new antibiotics ($2bn)
GoinPharma
Big Pharma
R&D
antibiotics
Flag link:
Aradigm crashes after FDA panel votes down antibiotic
Aradigm crashes after FDA panel votes down antibiotic
Fierce Biotech
Aradigm
FDA
advisory panels
antibiotics
Linhaliq
Flag link:
Bayer’s antibiotic drug-device combo fails in late-stage trial
Bayer’s antibiotic drug-device combo fails in late-stage trial
Drug Delivery Business News
Bayer
drug-device combos
antibiotics
Amikacin
pneumonia
Flag link:
New antibiotic therapies: what future?
New antibiotic therapies: what future?
GoinPharma
antibiotics
Merck
Paratek
Tetraphase Pharmaceuticals
Motif Biosciences
The Medicines Company
Flag link:
Roche ties a $387M knot with Warp Drive Bio in collaboration spotlighting new classes of antibiotics
Roche ties a $387M knot with Warp Drive Bio in collaboration spotlighting new classes of antibiotics
Endpoints
Roche
Warp Drive Bio
antibiotics
R&D
Flag link:
Shooting for PhIII, Spero tees up a new lead antibiotic in-licensed cheap as it lines up $86M IPO
Shooting for PhIII, Spero tees up a new lead antibiotic in-licensed cheap as it lines up $86M IPO
Endpoints
Spero
antibiotics
clinical trials
Orapenem
SPR994
Flag link:
Motif delivers more strong data on its antibiotic
Motif delivers more strong data on its antibiotic
Biopharma Dive
Motif Biosciences
antibiotics
Iclaprim
skin infections
Flag link:
WHO raises alarm on lack of new antibiotics
WHO raises alarm on lack of new antibiotics
GoInPharma
WHO
antibiotics
drug development
Flag link:
Nabriva shares leap higher on antibiotic trial success
Nabriva shares leap higher on antibiotic trial success
BioPharma Dive
Nabriva Therapeutics
antibiotics
clinical trials
lefamulin
Flag link:
Patients Not Always Informed of Study's Purpose in Noninferiority Trials
Patients Not Always Informed of Study's Purpose in Noninferiority Trials
RAPS.org
patients
noninferiority trials
antibiotics
clinical trials
Flag link:

Pages